Cough, Cold and Allergy (Hay Fever) Remedies in Hungary
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN HUNGARY
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
the Flu Season Drives Seasonal Demand
Self-medication and Paracetamol
Allergies Are on the Rise
Competitive Landscape
GlaxoSmithKline Consumer Healthcare Maintains Its Lead
Sales Are Dominated by Major Multinationals
Innovation Versus Tradition
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 Sales of Decongestants by Category: Value 2013-2018
Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Benefits From Changing Consumer Lifestyles
Trends and Events in Consumer Health
Advertising Remains Key To Success
the Rise of Internet Retailing
Healthy Is the New Trendy
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018
Market Data
Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Sources
Summary 1 Research Sources
Cough, cold and allergy (hay fever) remedies is the largest OTC category, thanks to continuous demand and wide supply. Regarding cough and cold remedies, January is generally the start of the flu season in Hungary, and the length of the season may vary. Since the number of sick people can increase rapidly, these weeks are essential for manufacturers. However, demand for cough and cold remedies is usually seen throughout the period from autumn to spring. Discounting strategies, such as multipacks...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Hungary report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.